Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) EV/Assets Ratio: 0.89x

Is Bio-Rad Laboratories, Inc.’s EV/Assets ratio high or low?

Bio-Rad Laboratories, Inc.'s EV/Assets ratio of 0.89x is 10% below its 5-year average of 0.99x, near the low end of its 5-year range (0.67x–1.61x).

As of Wednesday, June 17, 2026. 1.47% above its 12-month average of 0.88x.

BIO EV/Assets Ratio Chart

BIO EV/Assets Ratio
0.89x+15.58% 1Y
Zoom

BIO Average EV/Assets Ratio Chart

BIO Current vs Average EV/Assets Ratio Chart

BIO EV/Assets Ratio Metrics

EV/ASSETS RATIO

0.89x

EV/ASSETS RATIO AVG TTM

0.88x

EV/ASSETS RATIO AVG 3Y

0.89x

EV/ASSETS RATIO AVG 5Y

0.97x

EV/ASSETS RATIO AVG 10Y

1.23x

EV/ASSETS RATIO AVG 15Y

1.18x

EV/ASSETS RATIO AVG 20Y

1.20x

CURRENT VS TTM AVG

+1.47%

CURRENT VS 3Y AVG

+0.04%

CURRENT VS 5Y AVG

-8.19%

CURRENT VS 10Y AVG

-27.93%

CURRENT VS 15Y AVG

-24.29%

CURRENT VS 20Y AVG

-25.77%

BIO Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
Bio-Rad Laboratories, Inc. (BIO)$7.84B0.89x0.88x0.89x0.97x
Hims & Hers Health, Inc. (HIMS)vs ›$7.02B3.57x5.78x7.31x5.77x
Tempus AI, Inc. (TEM)vs ›$8.82B4.61x6.22x7.85x7.85x
Charles River Laboratories International, Inc. (CRL)vs ›$8.90B1.54x1.51x1.59x1.95x
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B0.56x0.52x0.58x0.69x
Baxter International Inc. (BAX)vs ›$10.57B0.92x0.91x1.05x1.32x
Revvity, Inc. (RVTY)vs ›$11.29B1.15x1.11x1.18x1.38x
Align Technology, Inc. (ALGN)vs ›$12.86B1.89x1.75x2.55x3.74x
The Cooper Companies, Inc. (COO)vs ›$13.14B1.24x1.36x1.62x1.75x
Medpace Holdings, Inc. (MEDP)vs ›$13.18B6.03x8.01x6.58x5.71x

Bio-Rad Laboratories, Inc. EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. EV/Assets Ratio FAQ

What is the EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The EV/Assets ratio for BIO stock is 0.89x.
Is Bio-Rad Laboratories, Inc.'s EV/Assets ratio high or low?
Bio-Rad Laboratories, Inc.'s EV/Assets ratio of 0.89x is 10% below its 5-year average of 0.99x, near the low end of its 5-year range (0.67x–1.61x).
What is the TTM average EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The TTM average EV/Assets ratio for BIO stock is 0.88x.
What is the 3Y average EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 3Y average EV/Assets ratio for BIO stock is 0.89x.
What is the 5Y average EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 5Y average EV/Assets ratio for BIO stock is 0.97x.
What is the 10Y average EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 10Y average EV/Assets ratio for BIO stock is 1.23x.
What is the 15Y average EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 15Y average EV/Assets ratio for BIO stock is 1.18x.
What is the 20Y average EV/Assets ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 20Y average EV/Assets ratio for BIO stock is 1.20x.

Bio-Rad Laboratories, Inc. EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-06-160.89x
2026-06-150.89x
2026-06-120.88x
2026-06-110.89x
2026-06-100.89x
2026-06-090.91x
2026-06-080.89x
2026-06-050.90x
2026-06-040.94x
2026-06-030.93x
2026-06-020.93x
2026-06-010.93x
2026-05-290.95x
2026-05-280.97x
2026-05-270.93x
2026-05-260.91x
2026-05-220.88x
2026-05-210.88x
2026-05-200.88x
2026-05-190.86x
2026-05-180.86x
2026-05-150.77x
2026-05-140.77x
2026-05-130.76x
2026-05-120.75x
2026-05-110.76x
2026-05-080.79x
2026-05-070.80x
2026-05-060.80x
2026-05-050.80x
2026-05-040.80x
2026-05-010.80x
2026-04-300.86x
2026-04-290.80x
2026-04-280.81x
2026-04-270.83x
2026-04-240.83x
2026-04-230.81x
2026-04-220.86x
2026-04-210.88x
2026-04-200.87x
2026-04-170.86x
2026-04-160.84x
2026-04-150.85x
2026-04-140.84x
2026-04-130.83x
2026-04-100.81x
2026-04-090.80x
2026-04-080.81x
2026-04-070.80x
2026-04-060.81x
2026-04-020.81x
2026-04-010.81x
2026-03-310.81x
2026-03-300.78x
2026-03-270.77x
2026-03-260.80x
2026-03-250.79x
2026-03-240.79x
2026-03-230.77x
2026-03-200.77x
2026-03-190.77x
2026-03-180.78x
2026-03-170.78x
2026-03-160.76x
2026-03-130.77x
2026-03-120.76x
2026-03-110.78x
2026-03-100.78x
2026-03-090.79x
2026-03-060.78x
2026-03-050.81x
2026-03-040.82x
2026-03-030.81x
2026-03-020.81x
2026-02-270.81x
2026-02-260.80x
2026-02-250.78x
2026-02-240.78x
2026-02-230.78x
2026-02-200.79x
2026-02-190.79x
2026-02-180.79x
2026-02-170.77x
2026-02-130.75x
2026-02-120.84x
2026-02-110.92x
2026-02-100.94x
2026-02-090.92x
2026-02-060.94x
2026-02-050.93x
2026-02-040.95x
2026-02-030.93x
2026-02-020.93x
2026-01-300.92x
2026-01-290.92x
2026-01-280.94x
2026-01-270.93x
2026-01-260.93x
2026-01-230.93x
2026-01-220.95x
2026-01-210.97x
2026-01-200.97x
2026-01-160.97x
2026-01-151.00x
2026-01-140.99x
2026-01-131.00x
2026-01-121.00x
2026-01-091.00x
2026-01-080.99x
2026-01-071.00x
2026-01-061.01x
2026-01-051.00x
2026-01-020.95x
2025-12-310.94x
2025-12-300.95x
2025-12-290.95x
2025-12-260.95x
2025-12-240.94x
2025-12-230.94x
2025-12-220.95x
2025-12-190.94x
2025-12-180.94x
2025-12-170.94x
2025-12-160.94x
2025-12-150.96x
2025-12-120.96x
2025-12-110.97x
2025-12-100.98x
2025-12-090.96x
2025-12-080.96x
2025-12-050.98x
2025-12-040.99x
2025-12-030.99x
2025-12-020.99x
2025-12-011.00x
2025-11-281.00x
2025-11-261.01x
2025-11-251.03x
2025-11-241.00x
2025-11-210.98x
2025-11-200.95x
2025-11-190.95x
2025-11-180.96x
2025-11-170.95x
2025-11-140.97x
2025-11-130.98x
2025-11-121.01x
2025-11-110.97x
2025-11-100.96x
2025-11-070.95x
2025-11-060.95x
2025-11-050.96x
2025-11-040.97x
2025-11-030.97x
2025-10-310.99x
2025-10-300.95x
2025-10-290.99x
2025-10-280.98x
2025-10-271.00x
2025-10-241.01x
2025-10-231.00x
2025-10-220.99x
2025-10-210.98x
2025-10-200.96x
2025-10-170.93x
2025-10-160.93x
2025-10-150.92x
2025-10-140.91x
2025-10-130.91x
2025-10-100.90x
2025-10-090.90x
2025-10-080.91x
2025-10-070.89x
2025-10-060.93x
2025-10-030.92x
2025-10-020.89x
2025-10-010.90x
2025-09-300.85x
2025-09-290.82x
2025-09-260.82x
2025-09-250.82x
2025-09-240.84x
2025-09-230.85x
2025-09-220.86x
2025-09-190.86x
2025-09-180.87x
2025-09-170.85x
2025-09-160.85x
2025-09-150.85x
2025-09-120.85x
2025-09-110.86x
2025-09-100.84x
2025-09-090.86x
2025-09-080.88x
2025-09-050.89x
2025-09-040.87x
2025-09-030.87x
2025-09-020.88x
2025-08-290.90x
2025-08-280.88x
2025-08-270.88x
2025-08-260.89x
2025-08-250.89x
2025-08-220.91x
2025-08-210.86x
2025-08-200.87x
2025-08-190.87x
2025-08-180.86x
2025-08-150.86x
2025-08-140.87x
2025-08-130.87x
2025-08-120.83x
2025-08-110.81x
2025-08-080.81x
2025-08-070.81x
2025-08-060.81x
2025-08-050.83x
2025-08-040.84x
2025-08-010.86x
2025-07-310.75x
2025-07-300.82x
2025-07-290.83x
2025-07-280.83x
2025-07-250.86x
2025-07-240.86x
2025-07-230.84x
2025-07-220.81x
2025-07-210.81x
2025-07-180.81x
2025-07-170.82x
2025-07-160.81x
2025-07-150.81x
2025-07-140.82x
2025-07-110.84x
2025-07-100.85x
2025-07-090.83x
2025-07-080.82x
2025-07-070.81x
2025-07-030.83x
2025-07-020.82x
2025-07-010.82x
2025-06-300.80x
2025-06-270.80x
2025-06-260.80x
2025-06-250.80x
2025-06-240.79x
2025-06-230.78x
2025-06-200.78x
2025-06-180.77x
2025-06-170.77x
2025-06-160.77x
2025-06-130.75x
2025-06-120.77x
2025-06-110.76x
2025-06-100.77x
2025-06-090.75x
2025-06-060.73x
2025-06-050.73x
2025-06-040.74x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz